Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1 by Manka, SW et al.
	   1	  
Classification:	  	  BIOLOGICAL	  SCIENCES:	  Biochemistry	  
	  
Structural	  insights	  into	  triple-­‐helical	  collagen	  cleavage	  by	  matrix	  metalloproteinase	  1	  	  Szymon	  W.	  Mankaa,	  Federico	  Carafolib,	  Robert	  Vissea,	  Dominique	  Bihanc,	  Nicolas	  Raynalc,	  	  Richard	  W.	  Farndalec,	  Gillian	  Murphyd,	  Jan	  J.	  Enghilde,	  Erhard	  Hohenesterb1	  and	  Hideaki	  	  Nagasea1	  	  aKennedy	  Institute	  of	  Rheumatology,	  Nuffield	  Department	  of	  Orthopaedics,	  Rheumatology	  	  and	  Musculoskeletal	  Sciences,	  University	  of	  Oxford,	  London,	  	  W6	  8LH,	  United	  Kingdom;	  	  bDepartment	  of	  Life	  Sciences,	  Imperial	  College	  London,	  London,	  SW7	  2AZ,	  United	  Kingdom;	  	  cDepartment	  of	  Biochemistry,	  University	  of	  Cambridge,	  Downing	  Site,	  	  Cambridge,	  CB2	  1QW	  United	  Kingdom;	  	  dDepartment	  of	  Oncology,	  University	  of	  Cambridge,	  Cancer	  Research	  UK,	  Cambridge	  Institute,	  Li	  Ka	  Shing	  Centre,	  Cambridge,	  CB2	  0RE,	  United	  Kingdom;	  and	  	  eCenter	  for	  Insoluble	  Protein	  Structure	  and	  Interdisciplinary	  Nanoscience	  Center	  at	  Department	  	  of	  Molecular	  Biology,	  University	  of	  Aarhus,	  Gustav	  Wieds	  Vej	  10C,	  Aarhus,	  DK-­‐8000,	  Denmark	  	  1To	  whom	  correspondence	  should	  be	  addressed:	  e.hohenester@imperial.ac.uk;	  	  hideaki.nagase@kennedy.ox.ac.uk	  	  
Corresponding	  author:	  Hideaki	  Nagase,	  Kennedy	  Institute	  of	  Rheumatology,	  University	  	  of	  Oxford,	  65	  Aspenlea	  Road,	  London,	  W6	  8LH,	  UK;	  Tel,	  44-­‐20-­‐8383-­‐4488;	  	  e-­‐mail,	  hideaki.nagase@kennedy.ox.ac.uk	  
	   2	  


















	   3	  
	  
Introduction	  The	  interstitial	  collagens	  I,	  II	  and	  III	  are	  the	  major	  structural	  proteins	  in	  connective	  tissues	  such	  as	  skin,	  bone,	  cartilage,	  tendon	  and	  blood	  vessels	  (1).	  They	  consist	  of	  three	  α	  chains	  with	  repeating	  Gly-­‐X-­‐Y	  triplets	  	  (X	  and	  Y	  are	  often	  proline	  and	  hydroxyproline,	  respectively)	  that	  intertwine	  each	  other	  to	  form	  a	  triple	  helix	  of	  ~300	  nm	  length	  (2).	  	  Interstitial	  collagens	  are	  resistant	  to	  most	  proteolytic	  enzymes,	  but	  vertebrate	  collagenases	  cleave	  them	  at	  a	  single	  site	  approximately	  ¾	  of	  the	  way	  from	  the	  N-­‐terminus	  of	  the	  triple	  helix,	  thus	  initiating	  collagenolysis	  (3).	  	  Owing	  to	  this	  unique	  activity,	  collagenases	  play	  important	  roles	  in	  embryo	  development,	  morphogenesis,	  tissue	  remodeling,	  wound	  healing,	  and	  human	  diseases,	  such	  as	  arthritis,	  cancer	  and	  atherosclerosis	  (4,	  5).	  	  Matrix	  metalloproteinase	  1	  (MMP-­‐1)	  is	  a	  typical	  vertebrate	  collagenase	  (3).	  	  It	  consists	  of	  an	  N-­‐terminal	  catalytic	  (Cat)	  domain	  containing	  an	  active-­‐site	  zinc	  ion	  and	  a	  C-­‐terminal	  hemopexin	  (Hpx)	  domain	  comprised	  of	  a	  four-­‐bladed	  β-­‐propeller,	  which	  are	  connected	  by	  	  a	  linker	  region	  (6,	  7).	  	  While	  the	  Cat	  domain	  can	  cleave	  a	  number	  of	  non-­‐collagenous	  proteins	  including	  heat-­‐denatured	  collagen	  (gelatin),	  its	  activity	  on	  native	  triple-­‐helical	  collagen	  is	  negligible.	  	  The	  combination	  of	  the	  Cat	  and	  Hpx	  domains	  is	  required	  for	  MMP-­‐1	  to	  be	  able	  to	  degrade	  native	  collagen,	  and	  this	  is	  true	  for	  all	  other	  collagenolytic	  MMPs,	  namely	  MMP-­‐2,	  MMP-­‐8,	  MMP-­‐13	  and	  MMP-­‐14	  (3).	  	  How	  collagenases	  interact	  with	  collagen	  and	  how	  the	  Hpx	  domain	  endows	  these	  enzymes	  with	  collagenolytic	  activity	  is	  not	  clearly	  understood.	  	  Another	  enigma	  of	  collagenolysis	  became	  apparent	  when	  the	  crystal	  structures	  of	  MMP-­‐1Cat	  (8-­‐10),	  MMP-­‐8Cat	  (11,	  12),	  and	  full-­‐length	  pig	  MMP-­‐1	  (6)	  were	  solved:	  The	  catalytic	  cleft	  of	  these	  enzymes	  is	  too	  narrow	  to	  accommodate	  collagen	  in	  its	  native	  triple-­‐helical	  conformation.	  	  A	  number	  of	  hypotheses	  have	  been	  proposed	  to	  explain	  how	  collagenases	  may	  destabilize	  and	  cleave	  triple-­‐helical	  collagen	  (13-­‐16),	  and	  we	  have	  experimentally	  demonstrated	  that	  MMP-­‐1	  unwinds	  triple-­‐helical	  collagen	  locally	  prior	  to	  peptide	  bond	  hydrolysis	  (17,	  18).	  	  A	  recent	  study	  mapped	  the	  interaction	  sites	  in	  MMP-­‐1	  and	  in	  triple-­‐helical	  collagen	  using	  NMR	  and	  proposed	  a	  model	  of	  collagen	  binding	  and	  unwinding	  (19).	  	  However,	  because	  the	  interactions	  between	  MMP-­‐1	  and	  collagen	  were	  not	  observed	  directly,	  a	  number	  of	  assumptions	  had	  to	  be	  made	  to	  derive	  a	  mechanism	  of	  collagenolysis.	  In	  this	  study,	  we	  have	  combined	  biochemical	  experiments	  with	  crystallographic	  structure	  determination	  to	  show	  how	  MMP-­‐1	  recognizes	  its	  unique	  cleavage	  site	  in	  interstitial	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collagens.	  Our	  results	  suggest	  that	  collagenolysis	  relies	  on	  multiple	  exosite	  interactions,	  which	  not	  only	  serve	  to	  position	  the	  scissile	  bond	  near	  the	  active	  site,	  but	  also	  assist	  in	  the	  local	  unfolding	  of	  the	  collagen	  triple	  helix	  that	  is	  required	  for	  cleavage	  to	  occur.	  	  
Results	  
The	  Cat	  and	  Hpx	  domains	  of	  MMP-­‐1	  cooperate	  in	  collagen	  binding.	  	  We	  first	  examined	  	  a	  catalytically	  inactive	  MMP-­‐1(E200A)	  mutant	  (residue	  numbering	  based	  on	  the	  proMMP-­‐1	  sequence)	  and	  its	  individual	  domains	  for	  binding	  to	  native	  collagen	  I.	  	  Full-­‐length	  MMP-­‐1(E200A)	  showed	  saturable	  collagen	  binding	  with	  an	  apparent	  KD	  of	  0.4	  μM,	  whereas	  	  the	  catalytic	  domain	  Cat(E200A)	  showed	  no	  detectable	  binding	  and	  the	  Hpx	  domain	  bound	  only	  weakly	  (Fig.	  1A).	  The	  Cat(E200A)	  domain	  did	  not	  bind	  to	  collagen	  I	  even	  when	  it	  was	  added	  together	  with	  increasing	  concentrations	  of	  the	  Hpx	  domain	  (Fig.	  S1A),	  suggesting	  that	  the	  Cat	  and	  Hpx	  domains	  bind	  collagen	  cooperatively	  only	  when	  they	  are	  linked	  together.	  	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  Fig.	  1	  near	  here	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	  	   The	  binding	  of	  MMP-­‐1(E200A)	  to	  collagen	  increased	  with	  temperature	  until	  collagen	  denatured	  above	  37	  °C	  (Fig.	  1B),	  indicating	  that	  MMP-­‐1	  prefers	  a	  looser	  triple	  helix,	  but	  not	  denatured	  collagen.	  The	  temperature-­‐dependent	  enhancement	  of	  MMP-­‐1(E200A)	  binding	  to	  collagen	  was	  substantially	  reduced	  by	  the	  active-­‐site	  inhibitor	  GM6001	  (Fig.	  1C).	  This	  effect	  was	  not	  observed	  below	  10	  °C,	  where	  little	  collagen	  cleavage	  occurs	  (17).	  	  No	  significant	  temperature-­‐dependent	  increase	  in	  collagen	  binding	  was	  observed	  with	  either	  the	  Cat(E200A)	  or	  Hpx	  domain	  alone	  (Fig.	  S1B	  and	  C).	  These	  results	  suggest	  that	  the	  active	  site	  cleft	  of	  MMP-­‐1	  participates	  in	  collagen	  binding	  at	  body	  temperature	  by	  stabilizing	  and/or	  inducing	  a	  looser	  collagen	  conformation.	  	  
	  
The	  MMP-­‐1-­‐binding	  motif	  in	  interstitial	  collagens.	  To	  identify	  the	  collagen	  residues	  interacting	  with	  MMP-­‐1,	  we	  screened	  the	  Collagen	  Toolkit	  library	  of	  triple-­‐helical	  peptides	  encompassing	  the	  entire	  collagen	  II	  sequence	  (20)	  for	  binding	  to	  MMP-­‐1(E200A).	  Only	  one	  peptide,	  Col	  II-­‐44,	  starting	  at	  the	  collagenase	  cleavage	  site	  G~LAGQR…	  (~	  indicates	  the	  scissile	  bond)	  was	  recognized	  by	  the	  enzyme	  (Fig.	  2).	  Col	  II-­‐43,	  which	  also	  contains	  the	  cleavage	  site	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but	  with	  fewer	  C-­‐terminal	  residues,	  did	  not	  bind	  MMP-­‐1(E200A).	  Further	  experiments	  with	  truncated	  and	  alanine-­‐substituted	  peptides	  identified	  the	  leucines	  at	  the	  P1'	  and	  P10'	  positions	  (nomenclature	  after	  Schechter	  and	  Berger	  (21))	  of	  collagen	  as	  important	  for	  MMP-­‐1(E200A)	  binding	  (Fig.	  S2A).	  A	  sequence	  alignment	  showed	  that	  the	  leucines	  at	  these	  two	  positions	  are	  conserved	  in	  all	  α	  chains	  of	  collagens	  I,	  II	  and	  III	  from	  different	  species	  	  (Fig.	  S2B).	  The	  consensus	  sequence	  for	  collagenase	  binding	  is	  G~(L/I)(A/L)-­‐GXY-­‐GXY-­‐GL(O/A)	  (P1'	  and	  P10'	  positions	  are	  bold;	  O,	  hydroxyproline).	  This	  motif	  is	  unique	  and	  not	  found	  elsewhere	  in	  collagens	  I,	  II	  and	  III.	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	   	   	   	   	   Fig.	  2	  near	  here	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  
	  
Mapping	  of	  the	  collagen-­‐binding	  regions	  of	  MMP-­‐1	  in	  solution.	  	  We	  then	  used	  hydrogen/deuterium	  exchange	  mass	  spectrometry	  (H/DXMS)	  to	  map	  the	  regions	  in	  MMP-­‐1	  involved	  in	  collagen	  binding.	  Five	  MMP-­‐1	  regions	  showed	  delayed	  deuterium	  incorporation	  in	  the	  presence	  of	  collagen	  I	  (Fig.	  3A,	  Fig.	  S3	  and	  Table	  S1):	  Residues	  145-­‐161	  (site	  1)	  and	  205-­‐215	  (site	  3)	  in	  the	  Cat	  domain,	  and	  residues	  266-­‐277	  (site	  4),	  283-­‐297	  (site	  5)	  and	  330-­‐346	  (site	  6)	  in	  the	  Hpx	  domain.	  Sites	  4	  and	  5	  were	  previously	  reported	  to	  reduce	  deuterium	  exchange	  upon	  binding	  to	  a	  triple-­‐helical	  peptide	  (22).	  	  Residues	  179-­‐193	  (site	  2)	  showed	  increased	  deuterium	  incorporation	  in	  the	  presence	  of	  collagen,	  suggesting	  that	  this	  region,	  which	  includes	  the	  loop	  between	  the	  fifth	  β-­‐strand	  and	  the	  second	  α-­‐ahelix	  of	  the	  Cat	  domain,	  is	  more	  exposed	  to	  the	  solvent	  in	  the	  collagen-­‐bound	  state.	  This	  loop	  region	  was	  previously	  characterized	  as	  important	  for	  the	  collagenolytic	  activity	  of	  MMP-­‐1	  (23),	  and	  our	  data	  suggest	  that	  it	  participates	  in	  collagenolysis	  dynamically.	  The	  combined	  H/DXMS	  results	  indicate	  	  the	  general	  orientation	  of	  the	  collagen	  triple	  helix	  binding	  to	  MMP-­‐1	  (Fig.	  3,	  dashed	  line).	  	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	   	   	   	   	   Fig.	  3	  near	  here	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	  
The	  S10'	  exosite	  in	  the	  Hpx	  domain.	  	  Considering	  the	  H/DXMS	  results	  and	  the	  importance	  for	  MMP-­‐1(E200A)	  binding	  of	  the	  two	  leucines	  at	  the	  P1'	  and	  P10'	  positions	  of	  collagen,	  we	  searched	  for	  hydrophobic	  sites	  in	  MMP-­‐1	  that	  could	  accept	  these	  residues.	  	  For	  MMP-­‐1	  to	  cleave	  the	  Gly(P1)-­‐Leu(P1')	  bond,	  the	  P1'	  Leu	  must	  be	  located	  close	  to	  the	  S1'	  pocket	  of	  the	  Cat	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domain.	  Using	  this	  constraint,	  we	  docked	  a	  modeled	  triple-­‐helical	  peptide	  to	  MMP-­‐1	  and	  identified	  candidate	  residues	  in	  the	  Hpx	  domain	  that	  might	  be	  involved	  in	  binding	  the	  P10'	  Leu	  (Fig.	  3A).	  They	  were	  mutated	  and	  the	  mutant	  proteins	  tested	  for	  their	  collagenolytic	  activity	  (Fig.	  3B).	  The	  most	  dramatic	  reduction	  of	  collagenase	  activity	  was	  observed	  with	  the	  F301Y	  single	  mutant	  and	  the	  I271A/R272A	  double	  mutant,	  which	  exhibited	  10	  %	  and	  4	  %	  of	  wild-­‐type	  activity,	  respectively.	  Together,	  Phe301,	  Ile271	  and	  Arg272	  in	  the	  Hpx	  domain	  participate	  in	  forming	  the	  hydrophobic	  S10'	  binding	  pocket,	  or	  exosite.	  Ile271	  and	  Arg272	  were	  identified	  in	  the	  H/DXMS	  experiment	  as	  part	  of	  site	  4.	  Phe301	  is	  located	  between	  H/DXMS	  sites	  5	  and	  6.	  	  It	  was	  not	  detected	  by	  H/DXMS	  analysis	  most	  likely	  because	  its	  backbone	  amide	  is	  buried	  in	  the	  Hpx	  domain.	  	  
Crystal	  structure	  of	  an	  MMP-­‐1(E200A)-­‐collagen	  peptide	  complex.	  	  Based	  on	  the	  results	  	  of	  the	  collagen	  peptide	  binding	  studies,	  we	  designed	  a	  triple-­‐helical	  collagen	  peptide	  for	  co-­‐crystallization	  with	  MMP-­‐1(E200A).	  The	  peptide	  spans	  positions	  P7-­‐P17'	  of	  the	  collagen	  II	  cleavage	  site	  and	  is	  capped	  by	  two	  and	  three	  non-­‐native	  Gly-­‐Pro-­‐Hyp	  triplets	  at	  the	  N-­‐	  and	  	  C-­‐termini,	  respectively,	  to	  enhance	  triple-­‐helicity	  (Fig.	  4A).	  	  The	  melting	  temperature	  of	  this	  peptide	  was	  31	  °C	  (Fig.	  S4).	  	  The	  peptide	  formed	  a	  stable	  complex	  with	  MMP-­‐1(E200A)	  in	  solution	  (Fig.	  S5).	  	  Crystals	  of	  the	  complex	  were	  grown	  at	  room	  temperature	  and	  used	  to	  determine	  the	  structure	  at	  3.0	  Å	  resolution	  (Table	  S2).	  	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	   	   	   	   	   Fig.	  4	  near	  here	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	  
	  	   The	  overall	  structure	  of	  human	  MMP-­‐1(E200A)	  in	  complex	  with	  collagen	  is	  similar	  to	  those	  reported	  for	  full-­‐length	  pig	  (6)	  and	  human	  (7)	  	  MMP-­‐1	  without	  collagen.	  The	  collagen	  peptide	  in	  the	  complex	  with	  MMP-­‐1(E200A)	  is	  an	  uninterrupted	  triple	  helix	  ~115	  Å	  in	  length	  and	  bent	  by	  ~10°	  near	  the	  Cat-­‐Hpx	  junction	  (Fig.	  4B	  and	  Fig.	  S6A).	  The	  three	  chains	  of	  the	  collagen	  triple	  helix	  are	  arranged	  with	  the	  characteristic	  one	  residue	  stagger,	  resulting	  in	  	  a	  leading	  (L),	  middle	  (M)	  and	  trailing	  (T)	  chain	  (24).	  	  All	  three	  chains	  contribute	  to	  MMP-­‐1(E200A)	  binding,	  creating	  an	  extensive	  interaction	  surface	  spanning	  nearly	  60	  Å	  in	  length.	  	  Complex	  formation	  buries	  480	  Å2	  of	  solvent-­‐accessible	  surface	  of	  the	  L	  chain,	  440	  Å2	  of	  the	  M	  chain,	  and	  370	  Å2	  of	  the	  T	  chain.	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Interactions	  between	  MMP-­‐1(E200A)	  and	  the	  collagen	  peptide.	  	  The	  majority	  of	  	  the	  interactions	  between	  the	  collagen	  peptide	  and	  the	  Cat	  domain	  are	  of	  a	  polar	  nature	  	  (Fig.	  4C,	  Fig.	  S6B	  and	  Fig.	  S7B).	  	  Of	  the	  three	  collagen	  chains,	  the	  L	  chain	  is	  closest	  to	  the	  active	  site	  of	  MMP-­‐1,	  but	  the	  S1'	  pocket	  remains	  empty.	  The	  residue	  closest	  to	  the	  S1'	  pocket	  is	  Gln(P4'L)	  (residues	  are	  identified	  by	  their	  position	  relative	  to	  the	  scissile	  bond	  and	  a	  subscript	  designating	  the	  collagen	  chain).	  The	  side	  chain	  of	  Gln(P4'L)	  forms	  a	  hydrogen	  bond	  with	  	  the	  backbone	  amide	  of	  Tyr221	  at	  the	  entrance	  of	  the	  S1'	  pocket,	  and	  the	  backbone	  amide	  of	  Gln(P4'L)	  forms	  a	  hydrogen	  bond	  with	  the	  side	  chain	  of	  Asn161.	  	  Leu(P1'L)	  is	  9	  Å	  away	  from	  the	  S1'	  pocket	  and	  stabilized	  by	  a	  hydrophobic	  contact	  with	  the	  zinc	  ligand	  His203.	  	  The	  Arg(P5'L)	  side	  chain	  and	  backbone	  amide	  form	  hydrogen	  bonds	  with	  the	  side	  chain	  of	  Tyr218	  and	  the	  carbonyl	  oxygen	  of	  Pro219,	  respectively.	  	  The	  M	  chain	  makes	  only	  a	  single	  contact	  with	  the	  Cat	  domain,	  between	  the	  side	  chain	  of	  Gln(P4'M)	  and	  the	  side	  chain	  of	  Tyr218.	  The	  T	  chain,	  on	  the	  other	  hand,	  makes	  extensive	  interactions	  with	  the	  upper	  part	  of	  	  the	  substrate	  binding	  cleft,	  including	  five	  hydrogen	  bonds	  (Fig.	  4C,	  Fig.	  S6B	  and	  Fig.	  S7B).	  	  Some	  of	  these	  hydrogen	  bonds	  are	  identical	  to	  those	  formed	  with	  a	  cysteine-­‐switch	  sequence	  (25-­‐28)	  in	  proMMPs	  and	  with	  a	  predicted	  peptide	  substrate	  (29).	  	   The	  interactions	  between	  the	  collagen	  peptide	  and	  the	  Hpx	  domain	  are	  a	  combination	  of	  polar	  and	  apolar	  contacts,	  and	  are	  mediated	  mainly	  by	  the	  M	  chain	  (Fig.	  4D,	  Fig.	  S6B	  and	  	  Fig.	  S7B).	  	  Consistent	  with	  our	  mutagenesis	  results,	  the	  side	  chain	  of	  Leu(P10'M)	  is	  bound	  in	  	  a	  hydrophobic	  S10'	  exosite	  pocket	  delineated	  by	  Ile271,	  Met276,	  Phe301,	  Trp302	  and	  the	  alkyl	  portion	  of	  Arg272	  (Fig.	  4D	  and	  Fig.	  S6B).	  The	  S10'	  pocket	  is	  surrounded	  by	  polar	  residues	  (Arg272,	  Glu274,	  Arg285	  and	  Gln335)	  that	  make	  a	  total	  of	  five	  hydrogen	  bonds	  with	  	  the	  collagen	  peptide	  (Fig.	  S7B).	  The	  interactions	  at	  the	  S10'	  exosite	  are	  critical	  for	  collagen	  recognition	  and	  collagenolysis	  by	  MMP-­‐1	  (Fig.	  3B).	  In	  addition,	  Ile(P7'M)	  forms	  hydrophobic	  interactions	  with	  Val300	  and	  Phe301.	  The	  M	  and	  T	  chains	  make	  van	  der	  Waals	  contacts	  with	  Phe289	  and	  Tyr290,	  but	  these	  interactions	  evidently	  are	  not	  critical,	  since	  the	  triple	  mutant	  MMP-­‐1(F289A/Y290A/P291A)	  retains	  76%	  of	  wild-­‐type	  collagenase	  activity	  (Fig.	  3B).	  	  	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	   	   	   	   	   Fig.	  5	  near	  here	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	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Implications	  for	  collagenolysis.	  	  The	  way	  in	  which	  the	  collagen	  peptide	  is	  bound	  to	  	  the	  active-­‐site	  cleft	  of	  MMP-­‐1(E200A)	  	  is	  more	  compatible	  with	  cleavage	  of	  the	  Gly(P3'L)-­‐Gln(P4'L)	  bond	  instead	  of	  the	  canonical	  Gly(P1)-­‐Leu(P1')	  bond	  (30).	  To	  test	  whether	  MMP-­‐1	  can	  cleave	  also	  before	  Gln(P4'),	  we	  performed	  N-­‐terminal	  sequencing	  of	  the	  products	  generated	  by	  active	  MMP-­‐1	  at	  25	  °C	  and	  37	  °C.	  We	  found	  that	  only	  the	  Gly(P1)-­‐Leu(P1')	  bond	  was	  cleaved	  in	  the	  peptide,	  as	  in	  native	  collagen	  II,	  and	  concluded	  that	  the	  mode	  of	  collagen	  binding	  in	  the	  crystallized	  complex	  is	  unproductive.	  	  However,	  the	  helical	  symmetry	  of	  homotrimeric	  collagen	  allows	  the	  productive	  binding	  mode	  to	  be	  readily	  achieved	  after	  axial	  rotation	  of	  the	  peptide	  and	  it	  differs	  from	  the	  observed	  complex	  only	  in	  the	  register	  of	  	  the	  chain	  passing	  through	  the	  active	  site	  cleft	  (Fig.	  5	  and	  Fig.	  S7).	  	  If	  Leu(P10'L)	  instead	  of	  Leu(P10'M)	  is	  made	  to	  occupy	  the	  hydrophobic	  S10'	  exosite,	  the	  T	  chain	  becomes	  the	  strand	  that	  interacts	  most	  closely	  with	  the	  active	  site,	  and	  now	  Leu(P1'T)	  is	  situated	  near	  the	  S1'	  pocket,	  i.e.	  the	  register	  of	  the	  chain	  in	  the	  active	  site	  cleft	  is	  changed	  by	  one	  triplet.	  	  The	  third	  possible	  arrangement	  with	  Leu(P10'T)	  in	  the	  S10'	  exosite	  is	  also	  unproductive	  and	  not	  further	  considered.	  Notably,	  the	  productive	  chain	  arrangement	  with	  Leu(P1'T)	  near	  the	  S1'	  pocket	  does	  not	  alter	  any	  of	  the	  extensive	  interactions	  with	  the	  upper	  part	  of	  the	  substrate	  binding	  cleft	  (now	  made	  by	  the	  M	  chain)	  or	  with	  the	  S10'	  exosite	  in	  the	  Hpx	  domain	  (now	  made	  by	  	  the	  L	  chain)	  (Fig.	  5	  and	  Fig.	  S7).	  	  By	  contrast,	  the	  T	  chain	  loses	  several	  contacts	  around	  	  the	  active	  site	  that	  were	  observed	  with	  the	  L	  chain	  in	  the	  crystal	  structure,	  in	  particular	  	  the	  hydrogen	  bonds	  between	  the	  Gln(P4'L)	  side	  chain	  and	  the	  Tyr221	  backbone	  amide	  and	  between	  the	  Arg(P5'L)	  side	  chain	  and	  the	  Tyr218	  side	  chain	  (Fig.	  S7).	  The	  fewer	  contacts	  of	  	  the	  T	  chain	  may	  make	  it	  more	  prone	  to	  local	  unfolding	  and	  insertion	  of	  Leu(P1'T)	  into	  the	  S1'	  pocket.	  	  The	  energy	  difference	  between	  the	  productive	  and	  unproductive	  complex	  is	  likely	  to	  be	  small	  and	  we	  think	  that	  the	  two	  forms	  co-­‐exist	  in	  solution.	  	  The	  unproductive	  binding	  mode	  may	  be	  favored	  by	  the	  E200A	  mutant	  of	  MMP-­‐1,	  or	  the	  unproductive	  complex	  may	  have	  crystallized	  preferentially	  in	  our	  experiment.	  	   Starting	  from	  the	  modeled	  productive	  complex	  (Fig.	  S7),	  it	  proved	  straightforward	  to	  achieve	  the	  first	  transition	  state	  of	  collagenolysis,	  in	  which	  one	  collagen	  chain	  is	  inserted	  into	  the	  active	  site	  (Fig.	  6).	  By	  stretching	  the	  P1'-­‐P6'	  region	  of	  the	  T	  chain	  and	  reorienting	  three	  residues	  preceding	  the	  scissile	  bond,	  it	  was	  possible	  to	  insert	  Leu(P1'T)	  into	  the	  S1'	  pocket	  in	  	  a	  manner	  that	  fully	  agrees	  with	  the	  observed	  binding	  mode	  of	  single-­‐chain	  peptidomimetic	  MMP	  inhibitors	  (8,	  31).	  	  The	  Cα	  atom	  of	  Leu(P1'T)	  moves	  by	  less	  than	  4	  Å	  during	  this	  localized	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excursion	  from	  the	  regular	  triple-­‐helical	  structure,	  and	  only	  four	  collagen	  inter-­‐chain	  hydrogen	  bonds	  are	  broken	  in	  the	  transition	  state.	  We	  propose	  that	  the	  energy	  penalty	  for	  this	  local	  unfolding	  event	  is	  compensated	  by	  the	  favorable	  interactions	  that	  the	  enzyme	  forms	  with	  the	  looped-­‐out	  collagen	  chain.	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  	   	   	   	   	   Fig.	  6	  near	  here	  	   	   	   	   	   -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐	  
	  
Discussion	  Our	  study	  has	  revealed	  an	  unprecedented	  proteinase-­‐substrate	  interaction.	  The	  most	  striking	  feature	  of	  the	  MMP-­‐1-­‐collagen	  complex	  is	  the	  extensive	  interaction	  of	  all	  three	  collagen	  chains	  with	  the	  two	  domains	  of	  MMP-­‐1,	  which	  explains	  the	  strict	  requirement	  of	  the	  Hpx	  domain	  for	  efficient	  collagenolysis	  (3).	  	  The	  individual	  Cat	  or	  Hpx	  domains	  of	  MMP-­‐1	  showed	  very	  little	  collagen	  binding	  in	  our	  experiments,	  but	  when	  linked	  together,	  they	  acted	  cooperatively	  in	  	  a	  temperature-­‐dependent	  manner.	  The	  affinity	  for	  collagen	  I	  increased	  up	  to	  37	  °C,	  	  a	  temperature	  that	  would	  not	  cause	  collagen	  to	  denature	  within	  the	  time	  frame	  of	  	  the	  experiment	  (~2	  h)	  (32).	  	  Above	  this	  temperature	  the	  binding	  sharply	  decreased.	  	  This	  temperature-­‐dependence,	  which	  is	  also	  unusually	  pronounced	  in	  the	  rate	  of	  collagen	  cleavage	  by	  MMP-­‐1	  (33),	  can	  be	  explained	  by	  the	  relative	  thermoflexibility	  of	  the	  triple	  helix	  at	  the	  collagenase	  cleavage	  site	  (34-­‐37)	  and	  the	  contribution	  of	  inter-­‐domain	  flexibility	  of	  	  MMP-­‐1.	  The	  cooperative	  binding	  is	  therefore	  energetically	  most	  favored	  close	  to	  body	  temperature,	  when	  the	  triple	  helix	  is	  locally	  looser	  but	  the	  overall	  fold	  of	  the	  substrate	  is	  still	  maintained.	  A	  complete	  loss	  of	  triple-­‐helicity	  makes	  collagen	  bind	  less	  tightly	  to	  MMP-­‐1,	  as	  evidenced	  from	  a	  Km	  value	  of	  ~1	  μM	  for	  collagen	  I	  compared	  with	  4-­‐7	  μM	  for	  gelatin	  (38).	  	  	  The	  small	  active-­‐site	  inhibitor	  GM6001	  abolished	  the	  temperature-­‐dependent	  increase	  of	  collagen	  binding,	  indicating	  that	  the	  catalytic	  site	  of	  MMP-­‐1	  is	  not	  only	  involved	  in	  the	  final	  hydrolysis	  step,	  but	  also	  in	  the	  unfolding	  machinery,	  which	  uses	  the	  active	  site	  to	  extract	  one	  collagen	  chain	  to	  form	  the	  first	  transition	  state	  of	  collagenolysis	  (Fig.	  6).	  Apart	  from	  providing	  a	  favorable	  environment	  for	  the	  loose	  triple	  helix	  at	  the	  cleavage	  site,	  what	  other	  mechanism(s)	  might	  contribute	  to	  collagenolysis?	  Comparison	  of	  the	  crystal	  structure	  of	  proMMP-­‐1	  (28)	  with	  the	  structure	  of	  the	  activated	  form	  of	  MMP-­‐1(E200A)	  (6,	  7)	  suggested	  that	  the	  Cat-­‐Hpx	  linker	  region	  confers	  inter-­‐domain	  flexibility.	  	  Such	  flexing	  was	  further	  demonstrated	  for	  MMP-­‐1	  by	  NMR	  and	  small	  angle	  X-­‐ray	  scattering	  studies	  (39,	  40),	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and	  seems	  to	  be	  a	  common	  property	  of	  MMPs	  (41,	  42).	  Our	  crystal	  structure	  of	  MMP-­‐1	  bound	  to	  collagen	  has	  a	  more	  closed	  conformation	  than	  free	  MMP-­‐1	  (Fig.	  S8).	  This	  change	  in	  inter-­‐domain	  angle	  is	  accompanied	  by	  the	  bending	  of	  the	  collagen	  peptide	  at	  a	  point	  half-­‐way	  between	  the	  Cat	  and	  Hpx	  domains.	  Thus,	  domain	  motions	  in	  MMP-­‐1	  may	  facilitate	  structural	  changes	  in	  the	  triple	  helix.	  Our	  structural	  results	  show	  how	  the	  two	  domains	  of	  MMP-­‐1	  anchor	  two	  of	  the	  collagen	  chains	  (middle	  and	  leading	  in	  the	  productive	  complex)	  and	  position	  	  the	  third	  (trailing)	  chain	  near	  the	  active	  site.	  The	  paucity	  of	  interactions	  made	  by	  the	  trailing	  chain,	  combined	  with	  its	  stretching	  by	  inter-­‐domain	  flexing	  of	  the	  enzyme,	  may	  assist	  in	  local	  collagen	  unfolding.	  	  Because	  the	  P1'	  residue	  of	  the	  trailing	  chain	  is	  poised	  above	  the	  S1'	  pocket	  in	  the	  productive	  complex	  with	  MMP-­‐1,	  transient	  excursions	  of	  the	  scissile	  bond	  can	  be	  efficiently	  captured	  by	  the	  enzyme,	  leading	  to	  the	  stabilization	  of	  the	  first	  transition	  state	  of	  collagenolysis	  (Fig.	  6).	  	  While	  thermal	  relaxation	  of	  the	  cleavage	  site	  is	  important	  for	  MMP-­‐1	  binding,	  this	  alone	  is	  not	  sufficient	  for	  efficient	  collagenolysis	  (17,	  36).	  We	  propose	  that	  mammalian	  collagenases	  do	  not	  serve	  merely	  as	  passive	  acceptors	  of	  spontaneously	  occurring	  unfolded	  collagen	  states	  (43,	  44),	  but	  promote	  a	  local	  perturbation	  of	  the	  triple	  helix	  that	  facilitates	  collagenolysis.	  	  The	  recently	  reported	  NMR	  study	  support	  this	  notion	  by	  demonstrating	  a	  weakening	  of	  the	  collagen	  interchain	  contacts	  in	  the	  complex	  with	  MMP-­‐1	  (19).	  	  	  	   Our	  mechanism	  of	  collagenolysis	  (Fig.	  6)	  differs	  from	  that	  derived	  from	  NMR	  experiments	  (19)	  in	  that	  it	  does	  not	  require	  a	  separation	  of	  the	  Cat	  and	  Hpx	  domains.	  Bertini	  et	  al.	  (19),	  who	  also	  used	  the	  E200A	  mutant	  of	  MMP-­‐1,	  found	  that	  the	  Cat	  domain	  interacted	  mainly	  with	  the	  L	  chain,	  and	  the	  Hpx	  domain	  mainly	  with	  the	  L	  and	  M	  chains.	  These	  results	  agree	  with	  our	  crystal	  structure	  of	  an	  unproductive	  complex.	  In	  their	  modeling,	  Bertini	  et	  al.	  (19)	  imposed	  a	  productive	  interaction	  of	  the	  L	  chain	  with	  the	  S1'	  pocket,	  which	  forced	  	  the	  breaking	  of	  the	  Cat-­‐Hpx	  interface.	  Our	  interpretation	  requires	  only	  small	  conformational	  changes	  in	  the	  enzyme,	  but	  postulates	  the	  co-­‐existence	  of	  productive	  and	  unproductive	  binding	  modes.	  The	  crystal	  structure	  of	  a	  bacterial	  collagenase	  comprising	  of	  a	  N-­‐terminal	  activator	  domain,	  a	  glycine-­‐rich	  linker	  and	  a	  peptidase	  domain	  has	  been	  reported	  recently	  (45).	  	  Like	  MMPs,	  this	  bacterial	  collagenase	  requires	  an	  ancillary	  activator	  domain	  (unrelated	  to	  the	  Hpx	  domain	  of	  MMPs)	  to	  cleave	  triple-­‐helical	  collagen.	  The	  authors	  proposed	  that	  the	  enzyme	  clamps	  collagen	  between	  the	  activator	  and	  peptidase	  domains	  of	  the	  saddle-­‐shaped	  structure.	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Our	  MMP-­‐collagen	  structure	  shows	  that	  MMP-­‐1	  binds	  collagen	  in	  an	  extended	  manner,	  rather	  than	  surrounding	  it.	  	  These	  differences	  notwithstanding,	  inter-­‐domain	  plasticity	  seems	  to	  be	  	  a	  common	  feature	  of	  enzymes	  that	  can	  cleave	  the	  intractable	  collagen	  triple	  helix.	  Most	  MMPs	  are	  believed	  to	  have	  specific	  substrate	  recognition	  sites	  distant	  from	  	  the	  catalytic	  site,	  which	  are	  referred	  to	  as	  exosites.	  Apart	  from	  the	  Hpx	  domains	  of	  collagenases,	  examples	  include	  the	  fibronectin	  type	  II	  repeats	  in	  MMP-­‐2	  and	  MMP-­‐9,	  which	  contribute	  to	  the	  binding	  and	  degradation	  of	  elastin,	  gelatin	  and	  type	  IV	  collagen	  (46).	  Recent	  NMR	  and	  mutagenesis	  studies	  of	  the	  Cat	  domain	  of	  MMP-­‐12	  characterized	  several	  exosites	  for	  elastin	  (47,	  48).	  Similar	  studies	  were	  carried	  out	  with	  the	  isolated	  Hpx	  domain	  of	  MMP-­‐1	  and	  	  a	  triple-­‐helical	  collagen	  peptide	  (40),	  and	  suggested	  a	  role	  for	  Phe282	  (Phe301	  in	  	  the	  numbering	  used	  in	  ref.	  40)	  in	  binding	  of	  collagen.	  However,	  the	  exact	  modes	  of	  interaction	  between	  the	  enzyme	  and	  the	  target	  substrate	  have	  not	  been	  elucidated	  in	  these	  studies.	  	  We	  show	  that	  Phe282	  remains	  buried	  in	  the	  Cat-­‐Hpx	  interface	  in	  the	  collagen–MMP-­‐1	  complex.	  Our	  crystal	  structure	  has	  revealed	  in	  detail	  the	  interactions	  that	  occur	  between	  collagen	  and	  full-­‐length	  MMP-­‐1,	  using	  the	  exosites	  in	  both	  the	  Cat	  and	  Hpx	  domains	  and	  	  a	  triple-­‐helical	  peptide	  long	  enough	  to	  define	  all	  relevant	  contacts.	  Defining	  the	  exosites	  in	  proteolytic	  enzymes	  has	  important	  implications	  for	  the	  development	  of	  specific	  inhibitors.	  	  The	  hydrophobic	  S10'	  exosite	  in	  MMP-­‐1	  is	  a	  particularly	  attractive	  target	  as	  it	  is	  essential	  for	  collagenolysis.	  Recent	  studies	  of	  Robichaud	  et	  al.	  (49)	  showed	  the	  importance	  of	  Leu	  at	  	  the	  P10’	  subsite	  of	  collagen	  III	  for	  the	  cleavage	  by	  MMP-­‐1.	  Non-­‐collagenous	  extracellular	  matrix	  and	  non-­‐matrix	  substrates	  are	  cleaved	  by	  the	  Cat	  domain	  of	  MMP-­‐1	  (16).	  Therefore,	  typical	  inhibitors	  targeting	  the	  S1'	  pocket	  block	  all	  MMP-­‐1	  activities,	  whereas	  inhibitors	  directed	  against	  the	  S10'	  exosite	  are	  predicted	  to	  selectively	  inhibit	  collagenolysis.	  This	  exosite	  of	  MMP-­‐1	  is	  largely	  conserved	  in	  other	  MMPs,	  but	  to	  our	  knowledge	  it	  is	  specific	  for	  collagenolytic	  activity.	  We	  propose	  that	  molecules	  specifically	  binding	  the	  S10'	  exosite	  be	  therapeutically	  useful	  in	  diseases	  associated	  with	  accelerated	  collagen	  breakdown	  such	  as	  arthritis,	  cancer,	  aneurysm	  and	  atherosclerosis.	  	  
Materials	  and	  Methods	  
Proteins	  and	  Peptides,	  Binding	  Assays,	  H/DXMS	  Analysis	  and	  Enzyme	  Activity	  Assay.	  Recombinant	  proMMP-­‐1(E200A),	  its	  Cat(E200A)	  and	  Hpx	  domains	  and	  MMP-­‐1	  variants	  were	  produced	  in	  E.	  coli.	  Collagen	  I	  was	  purified	  from	  Guinea	  pig	  skin	  and	  treated	  with	  pepsin.	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The	  library	  of	  triple-­‐helical	  peptides	  of	  human	  collagen	  II	  (Toolkit	  II)	  and	  all	  other	  collagen	  peptides	  were	  synthesized	  by	  Fmoc	  (N-­‐(9-­‐fluorenyl)methoxycarbonyl)	  chemistry.	  Collagen	  and	  peptide	  binding	  assays	  were	  carried	  out	  in	  ELISA	  format	  using	  biotinylated	  proteins	  and	  detected	  by	  streptavidin-­‐horseradish	  peroxidase	  system.	  Local	  hydrogen/deuterium	  exchange	  kinetics	  of	  MMP-­‐1(E200A)	  free	  and	  bound	  to	  collagen	  I	  were	  analyzed	  by	  digestion	  with	  pepsin	  and	  mass	  spectrometry	  and	  quantified	  using	  HX-­‐Express	  software.	  The	  collagenolytic	  activity	  of	  MMP-­‐1	  variants	  was	  determined	  by	  SDS-­‐PAGE	  and	  densitometric	  analyses	  of	  collagen	  I	  cleavage	  products.	  Detailed	  methods	  are	  described	  in	  SI	  Materials	  and	  Methods.	  	  
Crystallization,	  Data	  Collection	  and	  Structure	  Determination.	  MMP-­‐1(E200A)	  and	  	  the	  collagen	  peptide	  were	  mixed	  in	  a	  1:1.5	  molar	  ratio	  and	  the	  complex	  purified	  by	  size	  exclusion	  chromatography.	  Crystals	  of	  the	  complex	  were	  obtained	  at	  pH	  8.5	  and	  diffracted	  to	  3.0	  Å	  resolution.	  The	  structure	  was	  solved	  by	  molecular	  replacement	  and	  refined	  to	  a	  free	  R-­‐factor	  of	  0.273.	  Detailed	  methods	  are	  described	  in	  SI	  Materials	  and	  Methods.	  Data	  processing	  and	  refinement	  statistics	  are	  listed	  in	  Table	  S2.	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Figure	  legends	  
Fig.	  1.	  	  Binding	  of	  MMP-­‐1(E200A)	  to	  immobilized	  collagen	  I.	  (A)	  Binding	  of	  full-­‐length	  MMP-­‐1(E200A)	  and	  its	  individual	  Cat(E200A)	  and	  Hpx	  domains	  at	  20	  °C.	  	  (B)	  Binding	  of	  MMP-­‐1(E200A)	  at	  different	  temperatures.	  (C)	  Binding	  of	  1	  μM	  MMP-­‐1(E200A)	  in	  the	  presence	  of	  the	  active-­‐site	  inhibitor	  GM6001	  at	  different	  temperatures.	  	  	  
Fig.	  2.	  	  Screening	  of	  a	  triple-­‐helical	  peptide	  library	  of	  collagen	  II	  with	  proMMP-­‐1(E200A),	  MMP-­‐1(E200A),	  Hpx	  domain	  and	  Cat(E200A)	  domain.	  Error	  bars	  show	  standard	  deviations	  from	  three	  repeats.	  Critical	  Leu	  and	  Ile	  residues	  at	  P1'	  and	  P10'	  subsites	  are	  highlighted	  in	  	  the	  collagen	  II	  portion	  of	  the	  peptide	  sequences	  surrounding	  the	  collagenase	  cleavage	  site;	  	  ~,	  bond	  cleaved	  by	  collagenases.	  	  	  
Fig.	  3.	  	  Collagen	  I	  footprint	  on	  MMP-­‐1(E200A)	  determined	  by	  H/DXMS	  and	  mutagenesis.	  	  (A)	  Sites	  1	  and	  3-­‐6	  are	  protected	  from	  deuterium	  incorporation	  and	  site	  2	  showing	  enhanced	  deuterium	  incorporation	  upon	  collagen	  binding.	  	  The	  sites	  are	  mapped	  onto	  the	  crystal	  structure	  of	  MMP-­‐1(E200A)	  (7).	  Residues	  potentially	  involved	  in	  collagenolysis	  that	  were	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mutated	  are	  indicated.	  Dashed	  line,	  predicted	  collagen	  binding	  direction.	  (B)	  Relative	  initial	  velocities	  of	  collagen	  I	  cleavage	  by	  MMP-­‐1	  and	  its	  variants	  normalized	  to	  WT.	  	  	  
Fig.	  4.	  	  Crystal	  structure	  of	  the	  MMP-­‐1(E200A)-­‐triple	  helical	  collagen	  peptide	  complex.	  	  (A)	  Sequence	  of	  the	  collagen	  peptide	  used	  for	  co-­‐crystallization	  with	  MMP-­‐1(E200A).	  Residues	  within	  4	  Å	  distance	  of	  the	  enzyme	  in	  the	  complex	  are	  colored.	  The	  subsite	  designation	  is	  indicated	  for	  the	  leading	  chain.	  (B)	  Stereo	  view	  of	  the	  MMP-­‐1(E200A)-­‐collagen	  peptide	  complex.	  The	  collagen	  chains	  are	  colored	  cyan	  (L),	  green	  (M)	  and	  red	  (T)	  and	  the	  enzyme	  is	  shown	  as	  a	  grey	  surface	  with	  areas	  within	  4	  Å	  distance	  of	  the	  L,	  M	  and	  T	  chains	  colored	  correspondingly;	  magenta	  sphere,	  active-­‐site	  zinc	  ion.	  (C)	  Interactions	  of	  the	  collagen	  chains	  (colored	  as	  in	  B)	  with	  the	  active	  site	  cleft	  of	  MMP-­‐1(E200A).	  Hydrogen	  bonds	  are	  indicated	  by	  dashed	  lines.	  (D)	  Interactions	  of	  the	  collagen	  chains	  with	  the	  Hpx	  domain.	  Selected	  residues	  making	  enzyme-­‐substrate	  contacts	  are	  labeled	  with	  respective	  colors	  and	  shown	  in	  stick	  representation	  (N,	  dark	  blue,	  O,	  red).	  	  
Fig.	  5.	  	  Modes	  of	  collagen	  binding	  to	  MMP-­‐1.	  Shown	  is	  relationship	  between	  the	  unproductive	  and	  productive	  collagen	  binding	  modes	  (see	  text).	  In	  the	  sequence	  alignment	  on	  the	  left,	  	  the	  trailing	  chain	  is	  shown	  twice	  to	  emphasize	  the	  circular	  nature	  of	  the	  chain	  arrangement.	  The	  P1'	  and	  P10'	  residues	  are	  boxed	  and	  residues	  interacting	  with	  MMP-­‐1	  are	  in	  bold.	  	  The	  structural	  models	  on	  the	  right	  show	  that	  the	  unproductive	  and	  productive	  binding	  modes	  are	  related	  by	  a	  simple	  rotation/translation	  of	  the	  collagen	  triple	  helix.	  Note	  that	  only	  	  the	  interactions	  with	  one	  collagen	  chain	  are	  changed	  (L	  in	  the	  unproductive	  mode,	  T	  in	  	  the	  productive	  mode);	  the	  interactions	  with	  the	  other	  two	  chains	  are	  the	  same	  in	  both	  modes.	  	  	  	  
Fig.	  6.	  	  Model	  of	  the	  first	  transition	  state	  of	  collagenolysis	  based	  on	  the	  productive	  complex.	  The	  upper	  rim	  of	  the	  catalytic	  site	  cleft	  anchors	  the	  M	  chain	  (green)	  and	  the	  Hpx	  domain	  anchors	  the	  L	  chain	  (cyan).	  These	  interactions	  position	  the	  T	  chain	  above	  the	  active	  site.	  	  Inter-­‐domain	  flexing	  of	  the	  enzyme	  bends	  the	  collagen	  triple	  helix	  and	  facilitates	  the	  insertion	  of	  Leu(P1')	  of	  the	  T	  chain	  into	  the	  S1'	  pocket.	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Supporting	  Information	  
	  
SI	  Materials	  and	  Methods	  	  
Preparation	  of	  MMP-­‐1	  derivatives.	  ProMMP-­‐1(E200A)	  (N-­‐terminus	  of	  prodomain	  is	  number	  1),	  the	  Hpx	  domain	  of	  MMP-­‐1	  (252-­‐447),	  proMMP-­‐1Cat(E200A)	  (1-­‐242),	  and	  the	  proforms	  of	  the	  active	  MMP-­‐1	  variants	  were	  constructed	  using	  standard	  PCR	  methods,	  cloned	  in	  the	  pET3a	  vector,	   overexpressed	   in	   E.	   coli	  BL21	   DE3,	   refolded	   from	   inclusion	   bodies	   and	   purified	   as	  described	  previously	  (1).	  ProMMPs	  were	  activated	  with	  a	  catalytic	  domain	  of	  MMP-­‐3	  in	  a	  50:1	  molar	  ratio	  and	  1	  mM	  4-­‐aminophenyl	  mercuric	  acetate	  in	  TNC	  buffer	  (50	  mM	  Tris-­‐HCl	  pH	  7.5,	  150	  mM	  NaCl,	  10	  mM	  CaCl2,	  0.02	  %	  NaN3)	   for	  60-­‐120	  min	  at	  37	  °C.	  The	  mature	   forms	  were	  finally	  purified	  by	  Sephacryl	  S-­‐200	  gel	  filtration	  (GE	  Healthcare).	  	  
Purification	   of	   collagen	   I.	  Type	   I	   collagen	  was	  extracted	   from	  Guinea	  pig	  dermis.	  The	  skin	  was	  extensively	  scraped,	  cut	  into	  pieces,	  washed	  with	  saline,	  extracted	  with	  0.5	  M	  acetic	  acid	  with	  pepsin	  added	  to	  1/50	  of	  the	  total	  wet	  weight	  for	  24	  h	  at	  4	  °C,	  and	  collagen	  was	  purified	  as	  described	  (2).	  Yield	  was	  determined	  after	  freeze-­‐drying.	  	  
Synthesis	   of	   collagen	   peptides.	  A	  series	  of	   triple-­‐helical	   collagen	  peptides	   that	  collectively	  represent	   the	  whole	  molecule	   of	   human	   collagen	   II	   (Toolkit	   II)	   as	   well	   as	  mutant	   peptides	  	  (Fig.	  S2A)	  and	   the	  peptide	  used	   for	  co-­‐crystallization	  with	  MMP-­‐1(E200A)	  were	  synthesized	  by	   Fmoc	   (N-­‐(9-­‐fluorenyl)methoxycarbonyl)	   chemistry	   as	   C-­‐terminal	   amides	   on	   TentaGel	   R	  RAM	  resin	  in	  an	  Applied	  Biosystems	  Pioneer	  automated	  synthesizer	  and	  purified	  as	  described	  (3).	   	   Every	   peptide	   in	   the	   Toolkit	   contains	   27	   amino	   acids	   of	   collagen	   II	   (so	   called	   “guest”	  sequence),	  with	  9	  amino	  acid	  overlap	  between	   the	  neighbouring	  peptides,	   flanked	  by	  5	  GPP	  repeats	   and	   a	   GPC	   knot	   (“host”	   sequences)	   that	   impart	   triple-­‐helical	   conformation	   on	  	  the	   whole	   peptide.	   For	   exact	   sequences	   see	   (4).	   	   All	   peptides	   were	   verified	   by	   mass	  spectrometry	  and	  shown	  to	  adopt	  triple-­‐helical	  conformation	  by	  polarimetry.	  	  
Collagen	   I	   and	   collagen	  peptide	  binding	   assays.	  Proteins	   in	  50	  mM	  (CHES)	  buffer	  pH	  8.8	  containing	  200	  mM	  NaCl	  and	  10	  mM	  CaCl2	  were	  reacted	  with	  EZ	  link	  LC-­‐NHS	  biotin	  (Sigma)	  in	  water	  at	  a	  final	  1:2	  protein:biotin	  molar	  ratio	  for	  1	  h	  at	  room	  temperature.	  Excess	  biotin	  was	  removed	   by	   Sephadex	   G-­‐25M	   PD-­‐10	   column	   (GE	   Healthcare)	   equilibrated	   in	   TNC	   buffer.	  	  The	  biotinylation	  did	  not	   affect	   collagenase	   activity	   of	   active	  MMP-­‐1	   and	   collagen	  unfolding	  activity(5)	   of	   MMP-­‐1(E200A).	   For	   collagen	   binding	   assay,	   Costar®	   High	   Binding	   96-­‐well	  microtiter	  plates	  (Corning,	  UK)	  were	  coated	  with	  50	  μl	  of	  20	  μg/ml	  collagen	  I	   in	  TNC	  buffer,	  overnight	  at	  room	  temperature.	  They	  were	  washed	  with	  TNC	  buffer	  containing	  0.05	  %	  Tween	  20	  (TNC-­‐T)	  and	  blocked	  with	  3	  %	  bovine	  serum	  albumin	  (Sigma)	  in	  TNC-­‐T	  buffer.	  Biotinylated	  proteins	  at	  increasing	  concentrations	  were	  added	  in	  TNC	  buffer	  and	  incubated	  for	  2	  h	  at	  4-­‐40	  °C.	   The	   wells	   were	   then	   washed	   in	   TNC-­‐T	   buffer	   at	   the	   temperature	   of	   incubation	   and	   in	  temperature-­‐dependent	  binding	  experiments	  they	  were	  then	  fixed	  with	  3	  %	  p-­‐formaldehyde	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for	  30	  min.	  The	  fixing	  step	  was	  omitted	  in	  room	  temperature	  binding	  experiments.	  Plates	  were	  developed	   using	   streptavidin-­‐horseradish	   peroxidase	   conjugate	   (R&D,	   UK)	   and	   3,3',5,5'-­‐tetramethylbenzidine	   2-­‐Component	   Microwell	   Peroxidase	   Substrate	   KitTM	   (KPL,	   UK)	   for	  	  a	   fixed	   time.	   For	   the	   collagen	   peptide	   library	   (Toolkit	   II)	   screening	   the	   Costar	   plates	   were	  coated	  with	  a	  5	  μg/ml	  collagen	  peptide	  solution	  in	  10	  mM	  acetic	  acid,	  incubated	  overnight	  at	  4	  °C,	  washed	  and	  blocked	  as	  described	  above.	  Biotinylated	  proteins	  at	  1	  μM	  concentration	  were	  added	   and	   incubated	   1-­‐2	   h	   at	   room	   temperature.	   Plates	  were	   developed	   as	   in	   the	   collagen	  binding	  assay.	  All	  assays	  were	  carried	  out	  in	  a	  triplicate	  and	  compared	  analyses	  were	  always	  developed	  simultaneously.	  	  	  
H/DXMS	  experiment.	  We	  first	  established	  a	  peptic	  peptide	  mass	  mapping	  of	  MMP-­‐1(E200A)	  which	  was	  essential	  for	  H/D	  exchange	  localization.	  MMP-­‐1(E200A)	  was	  digested	  with	  pepsin	  by	  passing	  through	  a	  homemade	  2.1	  x	  50	  mm	  pepsin	  column	  based	  on	  POROS	  AL20	  material	  (Applied	  Biosystems)	  and	  the	  peptic	  fragments	  were	  separated	  on	  a	  2.1	  x	  250	  mm	  C18	  column	  (Grace/Vydac).	  The	  C18	  fractions	  were	  subjected	  to	  nano-­‐LC-­‐ESI	  and	  MALDI	  MS/MS	  analyses	  (Waters).	   The	   combined	   peptide	  mapping	   covered	   84%	   of	  MMP-­‐1(E200A)	   sequence	   (Table	  S1).	  For	  H/D	  exchange	  analyses	  15	  μM	  MMP-­‐1(E200A)	  was	  incubated	  with	  or	  without	  20	  μM	  collagen	  I	  at	  25	  °C	  for	  1	  h	  in	  25	  mM	  MOPS	  buffer	  containing	  150	  mM	  NaCl	  and	  10	  mM	  CaCl2	  (H2O-­‐MOPS-­‐NC)	  pH7.5	  and	  diluted	  5-­‐fold	   into	  25	  mM	  D2O-­‐MOPS-­‐NC	  pD7.5,	   so	   that	   the	   final	  D2O	  content	  was	  80	  %.	  Samples	  were	  collected	  from	  the	  H/D	  exchange	  reaction	  mix	  at	  various	  timepoints	  (5	  s	  –	  5	  h),	  cooled	  to	  0	  °C,	  acidified	   to	  pH	  2.5	  by	  addition	  of	  concentrated	   formic	  acid,	  and	  immediately	  passed	  through	  the	  pepsin	  column,	  followed	  by	  a	  2.1	  x	  20	  mm	  POROS	  R1	   (Applied	   Biosystems)	   trap	   column.	   The	   resultant	   peptides	   were	   then	   immediately	  separated	  on	  a	  2.1	   x	  50	  mm	  C18	   column	   (Grace/Vydac)	   at	  1	   °C	   and	  eluted	  directly	   into	   the	  Micromass	  Q-­‐TOF	  mass	  spectrometer	  (Waters).	  Deuterium	  exchanged	  spectra	  were	  assigned	  using	  the	  catalogue	  of	  MMP-­‐1	  peptic	  peptides	  (Table	  S1).	  Natural	  isotopic	  patterns	  of	  assigned	  MMP-­‐1(E200A)	  peptides	  as	  well	  as	   those	  of	  each	   time-­‐point	  of	  H/D	  exchange	  reaction	  were	  found	  in	  total	  ion	  chromatograms	  and	  identified	  in	  MS	  spectra	  by	  manual	  inspection.	  Centroid	  (average)	  mass	  of	  each	  isotopic	  pattern	  was	  computed	  using	  HX-­‐Express	  software	  (6),	  which	  enabled	  determination	  of	  a	  relative	  deuterium	  level	  in	  a	  peptide	  at	  given	  H/D	  exchange	  time-­‐point	  (Fig.	  S3B).	  	  
Collagenase	   activity	   assay.	   The	   wild-­‐type	   MMP-­‐1	   and	   its	   mutants	   were	   used	   at	  	  a	  concentration	  of	  10	  nM	  to	  digest	  4.5	  μM	  collagen	   I	   in	  TNC	  buffer	  at	  25	  °C.	  Reactions	  were	  stopped	  at	  different	  time-­‐points	  by	  the	  addition	  of	  SDS-­‐PAGE	  loading	  buffer	  containing	  20	  mM	  EDTA.	   Products	   were	   analyzed	   by	   SDS-­‐PAGE	   with	   7.5	   %	   total	   acrylamide	   under	   reducing	  conditions	   and	   the	   gels	   were	   stained	   with	   Coomassie	   Brilliant	   Blue	   R-­‐250.	   The	   percentage	  cleavage	   was	   measured	   by	   densitometry	   using	   ImageScanner	   III	   (GE	   Healthcare)	   and	  Phoretics	   1D	   (TotalLab)	   quantification	   software	   from	  which	   the	   initial	   rate	   of	   cleavage	  was	  calculated.	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Complex	   formation	   and	   crystallization.	  The	  MMP-­‐1(E200A)-­‐collagen	  peptide	  complex	   for	  crystallization	   was	   formed	   by	   dissolving	   2.2	   mg	   of	   lyophilized	   peptide	   in	   230	   μl	   of	  	  a	  concentrated	  MMP-­‐1(E200A)	  solution	  (23.5	  mg/ml	  protein	  in	  TNC	  buffer).	  After	  incubation	  for	   30	   minutes	   at	   room	   temperature,	   the	   mixture	   was	   subjected	   to	   size	   exclusion	  chromatography	   on	   a	   Superdex	   75	   HR10/30	   column	   (GE	   Healthcare)	   at	   room	   temperature	  (Fig.	   S5).	   The	   MMP-­‐1(E200A)-­‐collagen	   peptide	   complex	   was	   concentrated	   to	   8	   mg/ml	   and	  screened	  for	  crystallization	  in	  vapor	  diffusion	  sitting	  drops	  using	  a	  Mosquito	  nanolitre	  robot	  (TTP	  LabTech).	  Clusters	  of	  thin	  needles	  grew	  after	  2-­‐3	  days	  using	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  2%	  (v/v)	   Tacsimate	   pH	   8.0,	   16%	   (w/v)	   PEG	   3350	   as	   precipitant.	   These	   crystals	   were	   used	   to	  generate	   a	   seed	   stock	   using	   the	   Seed	   Bead	   kit	   (Hampton	   Research)	   according	   to	   the	  manufacturer’s	  protocol.	  Single	  needle-­‐shaped	  crystals	  of	  a	   few	  μm	  thickness	  were	  obtained	  by	  microseeding	  crystallization	  drops	  pre-­‐equilibrated	  in	  0.1	  M	  Tris-­‐HCl	  pH	  8.5,	  8-­‐11%	  (v/v)	  Tacsimate	  pH	  8.0,	  10-­‐12.5%	  (w/v)	  PEG	  3350.	  The	  crystals	  were	  flash-­‐frozen	  in	  liquid	  nitrogen	  after	  a	  brief	  soak	  in	  mother	  liquor	  supplemented	  with	  20%	  glycerol.	  	  
Crystal	  structure	  determination.	  Diffraction	  data	  were	  collected	  at	  100	  K	  on	  the	  microfocus	  beam	  line	  I24	  at	  the	  Diamond	  Light	  Source	  (Oxfordshire,	  UK).	  Many	  crystals	  were	  screened	  to	  identify	   a	   single	   good	   crystal,	   from	   which	   all	   data	   were	   collected.	   To	   minimize	   radiation	  damage,	  a	  fresh	  crystal	  volume	  was	  exposed	  after	  each	  20°	  of	  data	  collected,	  yielding	  a	  total	  of	  140°	   of	   usable	   data.	   The	   data	   were	   processed	   with	   MOSFLM	   (www.mrc-­‐lmb.cam.ac.uk/harry/mosflm)	   and	   programs	   of	   the	   CCP4	   suite	   (7).	   The	   MMP-­‐1-­‐collagen	  structure	  was	   solved	   by	  molecular	   replacement	   with	   PHASER	   (8)	   using	   the	   human	  MMP-­‐1	  structure	   (PDB	   entry	   2CLT)	   as	   a	   search	  model.	   After	   refinement	  with	   CNS	   (9),	   the	   electron	  density	  map	  calculated	  from	  the	  correctly	  positioned	  search	  model	  showed	  weak	  density	  for	  the	  collagen	   triple	  helix.	  A	  collagen	  peptide	  with	  poly-­‐Gly-­‐Ala-­‐Ala	   sequence	  was	  constructed	  based	  on	  PDB	  entry	  2WUH	  and	  positioned	  with	  PHASER.	  The	  model	  was	  completed	  using	  O	  (10)	  and	  refined	  with	  CNS	  (Table	  S2).	  Omit	  maps	  were	  used	  extensively	  to	  assign	  the	  correct	  register	   of	   the	   three	   collagen	   chains.	   The	   register	   of	   the	   leading	   chain	   passing	   through	   the	  active	  site	  cleft	  is	  defined	  unambiguously	  by	  the	  strong	  electron	  density	  of	  the	  Arg(P5'L)	  side	  chain.	   The	   two	  MMP-­‐1(E200A)-­‐collagen	   complexes	   in	   the	   asymmetric	   unit	   are	   very	   similar	  and	  tight	  non-­‐crystallographic	  symmetry	  restraints	  were	  applied	  throughout	  the	  refinement.	  The	   only	   deviations	   from	   non-­‐crystallographic	   symmetry	   are	   observed	   for	   the	   first	   three	  collagen	  triplets,	  which	  are	  not	  part	  of	  the	  collagen	  II	  sequence	  and	  do	  not	  interact	  with	  MMP-­‐1(E200A).	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Fig.	   S1.	   	   Binding	   of	   the	   individual	   domains	   of	  MMP-­‐1(E200A)	   to	   immobilized	   collagen	   I.	   (A)	   Cat(E200A)	   domain	   in	  	  
the	   presence	   of	   increasing	   concentrations	   of	   the	   Hpx	   domain.	   (B)	   Cat(E200A)	   domain	   at	   increasing	   temperatures.	  	  























Fig.	  S2.	  	  Identification	  of	  the	  MMP-­‐1(E200A)	  binding	  site	  in	  collagen	  II.	  (A)	  Binding	  of	  MMP-­‐1(E200A)	  to	  truncated	  and	  
alanine-­‐substituted	  (shown	  in	  blue)	  derivatives	  of	  peptide	  Col	  II-­‐44.	  Binding	  results	  are	  expressed	  as	  mean	  A450	  values	  ±	  
standard	  deviations	  from	  three	  independent	  experiments.	  Low	  binding	  data	  are	  shown	  in	  red	  text;	  O,	  hydroxyproline.	  
(B)	  Sequence	  alignment	  of	   interstitial	  collagens	  I,	   II	  and	  III	  from	  different	  species	  in	  the	  proximity	  of	  the	  collagenase-­‐
cleavage	  site.	  Sequences	  are	  derived	  from	  cDNA.	  Leu	  and	  Ile	  residues	  are	  highlighted	  in	  red,	  and	  residues	  at	  P1'	  and	  
P10'	  subsites	  are	  indicated.	  ~,	  Bond	  cleaved	  by	  collagenases.	  


































Fig.	   S3.	   	   Collagen	   I	   footprint	   on	   MMP-­‐1(E200A)	   determined	   by	   H/DXMS.	   (A)	   Sites	   protected	   from	   deuterium	  
incorporation	  (1	  and	  3-­‐6,	  circled)	  or	  showing	  enhanced	  deuterium	  incorporation	  (site	  2,	  square)	  upon	  collagen	  binding	  
are	   indicated	   in	  the	  MMP-­‐1(E200A)	  sequence.	  Site	  numbering	  and	  color	  coding	  corresponds	  with	  Fig.	  2A,	  where	  the	  
sites	   are	   mapped	   onto	   the	   crystal	   structure	   of	   MMP-­‐1(E200A).	   All	   analyzed	   peptides	   are	   shown	   as	   bars	   below	  	  
the	  sequence.	  Numbers	  in	  red	  refer	  to	  peptide	  numbers	  listed	  in	  Table	  S1.	  (B)	  H/D	  exchange	  time-­‐course	  analyses	  of	  
selected	  MMP-­‐1(E200A)	   peptic	   peptides;	   Unbound,	   free	  MMP-­‐1(E200A);	   Bound,	  MMP-­‐1(E200A)	   bound	   to	   collagen.	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Quantification	  of	  the	  exchange	  in	  MS	  spectra	  was	  performed	  using	  HX-­‐Express	  software	  (6).	  Centroid	  (average)	  mass	  of	  
each	   isotopic	  pattern	  was	  computed,	  which	  allowed	  determination	  of	  a	  relative	  deuterium	  level	   (rdl)	   in	  a	  peptide	  at	  
given	   H/D	   exchange	   time-­‐point	   by	   the	   following	   formula:	   rdl	   =	  m	   –	  m0,	   where	  m	   is	   the	   average	   mass	   after	   H/D	  
exchange	  and	  m0	  is	  the	  unexchanged	  average	  mass.	  Data	  are	  plotted	  by	  averaging	  results	  of	  two	  or	  three	  independent	  
experiments.	  The	  numbers	  in	  red	  shown	  with	  sequence	  delimiters	  correspond	  to	  the	  peptide	  numbers	  in	  A;	  2a	  and	  2b	  















Fig.	   S4.	   	  Melting	   curve	   of	   collagen	   peptide	   used	   for	   co-­‐crystallization	   with	   MMP-­‐1(E200A)	   determined	   by	   circular	  
dichroism	  (CD).	   	  The	  thermal	  transition	  of	  collagen	  peptide	  (10	  μM)	  in	  TNC	  buffer	  was	  determined	  in	  a	  Jasco	  815	  CD	  
instrument	   at	   222	   nm	  with	   a	   0.1	   cm	   pathlength.	   Temperature	   was	   increased	   at	   0.1	   oC/min.	   The	   first	   derivative	   of	  	  














Fig.	   S5.	   	   Solution	   binding	   of	   MMP-­‐1(E200A)	   to	   the	   collagen	   peptide.	   Analytical	   size	   exclusion	   (Superdex	   75)	  
chromatograms	  of	  the	  free	  MMP-­‐1(E200A)	  and	  its	  complex	  with	  the	  collagen	  peptide.	   	  








































Fig.	   S6.	   	   Overall	   structure	   of	   the	   MMP-­‐1(E200A)-­‐collagen	   peptide	   complex	   and	   details	   of	   the	   enzyme-­‐substrate	  
interactions.	   (A)	  Collagen	  bending.	  The	  collagen	  chains	  are	  colored	  cyan	  (L),	  green	  (M)	  and	  red	  (T).	  The	  dashed	   lines	  
indicate	  the	  helix	  axes	  in	  the	  N-­‐	  and	  C-­‐terminal	  regions	  of	  the	  collagen	  peptide,	  which	  is	  bent	  by	  ~10°	  halfway	  between	  
the	  Cat	  and	  Hpx	  domains.	  A	  magenta	  sphere	  represents	  the	  active-­‐site	  zinc	  ion.	  (B)	  Stereo	  views	  of	  the	  Cat	  and	  the	  Hpx	  
domains	  in	  the	  complex.	  The	  collagen	  chains	  are	  colored	  as	  in	  A.	  The	  MMP-­‐1(E200A)	  surface	  areas	  within	  4	  Å	  distance	  
of	  the	  collagen	  peptide	  are	  colored	  correspondingly.	  	  Selected	  residues	  making	  enzyme-­‐substrate	  contacts	  are	  labeled	  
and	   shown	   in	   stick	   representation	   (N,	   dark	   blue,	   O,	   red).	   Dotted	   lines	   denote	   hydrogen	   bonds.	   	   The	   S1'	   and	   S10'	  
pockets	  are	  indicated.	  	  













































Fig.	   S7.	   	   Model	   of	   the	   productive	   MMP-­‐1-­‐collagen	   complex	   and	   schematic	   representation	   of	   MMP-­‐1-­‐collagen	  
interactions.	  (A)	  Stereo	  image	  of	  the	  modeled	  productive	  complex.	  The	  collagen	  chains	  are	  in	  cyan	  (L),	  green	  (M)	  and	  
red	   (T),	   respectively.	   The	   MMP-­‐1(E200A)	   surface	   areas	   within	   4	   Å	   distance	   of	   the	   L,	   M	   and	   T	   chains	   are	   colored	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correspondingly.	   Collagen	   side	   chains	   are	   shown	   as	   sticks	   and	   have	   been	   labeled.	   (B)	   Schematic	   representation	   of	  
MMP-­‐1-­‐collagen	   interactions	   in	  the	  crystallized	  unproductive	  complex	  (left	  panels)	  and	  modeled	  productive	  complex	  
(right	  panels).	  MMP-­‐1	  residues	  are	  shown	  as	  circles	  (Cat	  domain)	  or	  squares	  (Hpx	  domain).	  Collagen	  subsites	  P1',	  P4'	  
and	   P10'	   are	   boxed.	   Dashed	   lines	   indicate	   hydrogen	   bonds	   (upper	   panels)	   and	   solid	   lines	   indicate	   contacts	   of	   4	   Å	  
distance	   or	   less	   (lower	   panels).	   Hydrophobic	   contacts	   are	   emphasized	   by	   red	   lines.	   BB,	   backbone;	   CO,	   main-­‐chain	  

















Fig.	   S8.	   	   Inter-­‐domain	   flexibility	   in	  MMP-­‐1.	   Shown	   is	   a	   stereoview	  of	   a	   superposition	  of	   the	   two	   crystallographically	  
independent	   molecules	   of	   free	   MMP-­‐1(E200A)	   (11)	   (molecule	   A,	   red;	   molecule	   B,	   green)	   and	   the	   MMP-­‐1(E200A)-­‐
collagen	  peptide	  complex	  (MMP-­‐1,	  cyan;	  collagen,	  gray).	  The	  structures	  were	  superimposed	  on	  the	  Hpx	  domains	  using	  
Pymol.	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Numbers	   in	   red	   refer	   to	   the	   peptides	   for	  which	   H/D	   exchange	   kinetics	   is	   shown	   in	   Figure	   S2.	  Many	   peptides	  were	  
identified	   in	   differently	   charged	   forms,	   especially	   with	   the	   electrospray	   ionization	   (ESI)	   method.	   Several	   ions	   were	  
detected	  multiple	  times,	  and	  the	  ranges	  of	  their	  observed	  mass-­‐over-­‐charge	  (m/z)	  values	  are	  shown.	  M,	  peptide	  mass;	  
M(experimental)	  was	  calculated	  as	  follows:	  M	  =	  ((m/z)	  z)	  -­‐	  z.	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Table	  S2.	  	  Crystallographic	  statistics	  of	  the	  MMP-­‐1(E200A)-­‐collagen	  peptide	  structure	  
Data	  collection	   	  
Space	  group	   P2	  
Unit	  cell	  dimensions	   	  
	  	  	  	  	  a,	  b,	  c	  (Å)	   76.67,	  102.24,	  80.73	  
	  	  	  	  	  α,	  β,	  γ	  (°)	   90,	  103.76,	  90	  
Asymmetric	  unit	  content	   2	  MMP-­‐1(E200A)-­‐collagen	  complexes	  
Solvent	  content	  (%)	   57	  
Resolution	  (Å)	   20-­‐3.0	  (3.16-­‐3.00)a	  
Rmerge	   0.128	  (0.400)	  
<I/σ(I)>	   5.0	  (2.2)	  
Completeness	  (%)	   86.8	  (77.9)	  
Multiplicity	   1.7	  (1.6)	  
Refinement	   	  
Resolution	  (Å)	   20-­‐3.0	  
Reflections	   20982	  
Protein	  atoms	   7368	  
Solvent	  atoms	   8	  Ca2+	  +	  4	  Zn2+	  +	  7	  H2O	  
Rwork/Rfree	   0.211/0.273	  
R.m.s.	  deviation	  bonds	  (Å)	   0.008	  
R.m.s.	  deviation	  angles	  (°)	   1.4	  
Ramachandran	  plot	  (%)b	   79.2,	  18.5,	  2.2,	  0.1	  
aValues	  in	  parentheses	  are	  for	  the	  highest	  resolution	  shell.	  
bPercentage	  of	  residues	  in	  core,	  allowed,	  generously	  allowed	  and	  disallowed	  regions	  (program	  PROCHECK).	  
	  
	  
	  
